Original news and analysis on international IP policy
The French Ministry of Social Affairs and Health announced today that the ministry has negotiated with pharmaceutical company Gilead to bring down the prices of hepatitis C medicines.
Legislation authorising the president to appoint the Register of Copyright in the United States Copyright Office is working its way through Congress. The “Register of Copyrights Selection and Accountability Act” garnered strong bipartisan support in the House of Representatives Judiciary…
Concerns continue to grow among civil society about provisions in a major trade agreement in the Asian region. Of specific worry is the intellectual property chapter containing in particular a data exclusivity clause, and the linkage between the investment chapter and the IP chapter.
A partnership of government agencies and organisations in the United States and United Kingdom have announced an investment of up to US$48 million into the development of new antibiotics and products to fight antibiotic resistant bacteria, with the aim of having two new antibiotics in human trials in the next five years.
A range of civil society organisations today issued a letter to European Union leadership urging support for a World Health Organization resolution that mandates a feasibility study on a fund for cancer research and development that delinks R&D costs from the price of health technologies.
The director of the United States Patent and Trademark Office (USPTO), Michelle Lee, today resurfaced after weeks of silence, speaking after the trilateral meeting of the US, European and Japan patent offices. Among her remarks was praise for Latin American countries for joining the Patent Prosecution Highway, which she said has already resulted in much faster patents in the region.
NEW DELHI, India -- Biopiracy is ongoing in many developing countries, and as long as there are no international obligations for patent applicants to disclose the origin of the genetic resources or traditional knowledge they use, the issue will endure, according to speakers at a recent conference in New Delhi. The broken conversation at the World Trade Organization needs to be rekindled so that an international regime of protection is set up, they said.
Public health group Médecins Sans Frontières (MSF) announced today that it has joined civil society organisations from 17 countries in Europe in filing a patent challenge at the European Patent Office to Gilead’s patent on sofosbuvir, an important treatment for hepatitis C.
The situation with IP rights in Russia is steadily deteriorating, which is mainly due to the recently imposed restrictions for foreign biopharmaceutical companies to participate in public procurement procedures in Russia, the encouragement of parallel imports, as well as the increased consumption of pirated software, according to recent statements of the Russian Ministry of Industry and Trade and local analysts in the field of IP protection.
European Patent Office President Benoît Battistelli today in Brussels expressed confidence that the first European Union unitary patent could be granted by the end of this year despite continued delays in the ratification process.But doubts remain.